![Quiver Logo](/static/img/logo-icon.png)
![FRES logo](https://quiver-logos.s3.us-east-2.amazonaws.com/fres.png)
Fresh2 Group Limited American Depositary Shares
Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view FRES Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of FRES by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by FRES's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to FRES
Recent picks made for FRES stock on CNBC
ETFs with the largest estimated holdings in FRES
Flights by private jets registered to FRES
![Quiver Logo](/static/img/logo-icon.png)